Influenza vaccine effectiveness in older adults compared with younger adults over five seasons

Vaccine

Volumn 36, Issue 10, 2018, Pages 1272-1278

  Russell, Kate ^a,b   Chung, Jessie R ^b   Monto, Arnold S ^c   Martin, Emily T ^c   Belongia, Edward A ^d   McLean, Huong Q ^d   Gaglani, Manjusha ^e   Murthy, Kempapura ^e   Zimmerman, Richard K ^f   Nowalk, Mary Patricia ^f   Jackson, Michael L ^g   Jackson, Lisa A ^g   Flannery, Brendan ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d MARSHFIELD CLINIC   (United States)

^e TEXAS A M COLLEGE OF MEDICINE   (United States)

^f UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^g KAISER PERMANENTE   (United States)

Author keywords

Human; Influenza; Influenza vaccine effectiveness; Influenza vaccines; Older adults

Indexed keywords

INFLUENZA VACCINE;

ACUTE RESPIRATORY TRACT DISEASE; ADULT; AGE; AGED; ARTICLE; COUGHING; DRUG EFFICACY; FEMALE; HUMAN; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA B VIRUS; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTPATIENT; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEASONAL VARIATION; YOUNG ADULT; ADOLESCENT; HEALTH SURVEY; IMMUNOLOGY; INFLUENZA; INFLUENZA A VIRUS (H1N1); INFLUENZA A VIRUS (H3N2); ODDS RATIO; OUTCOME ASSESSMENT; SEASON; UNITED STATES; VACCINATION; VERY ELDERLY; VIROLOGY;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; ODDS RATIO; OUTCOME ASSESSMENT (HEALTH CARE); PUBLIC HEALTH SURVEILLANCE; SEASONS; UNITED STATES; VACCINATION; YOUNG ADULT;

EID: 85041596163     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2018.01.045     Document Type: Article

References (40)

1. Centers for Disease Control and Prevention. People at High Risk of Developing Flu-Related Complications; 2016 < https://www.cdc.gov/flu/about/disease/high_risk.htm> [accessed 27 March 2017].
2. Thompson, W., Shay, D., Weintraub, E., Brammer, L., Cox, N., Anderson, L., et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 289:2 (2003), 179–186.
3. Zhou, H., Thompson, W., Viboud, C., Ringholz, C., Cheng, P., Steiner, C., et al. Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993–2008. CID 54:10 (2012), 1427–1436.
4. Reed, C., Chaves, S.S., Daily Kirley, P., Emerson, R., Aragon, D., Hancock, E.B., et al. Estimating influenza disease burden from population-based surveillance data in the United States. PloS One, 10(3), 2015, e0118369.
5. Grohskopf, L.A., Sokolow, L.Z., Broder, K.R., Olsen, S.J., Karron, R.A., Jernigan, D.B., et al. Prevention and control of seasonal influenza with vaccines. MMWR Recomm Rep 65 (2016), 1–54.
6. Bridges CB, Winquist AG, Fukuda K, Cox NJ, Singleton JA, Strikas RA. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2000;49:1-38; quiz CE1-7.
7. Ohmit, S.E., Thompson, M.G., Petrie, J.G., Thaker, S.N., Jackson, M.L., Belongia, E.A., et al. Influenza vaccine effectiveness in the 2011–2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. Clin Infect Dis 58 (2014), 319–327.
8. McLean, H.Q., Thompson, M.G., Sundaram, M.E., Kieke, B.A., Gaglani, M., Murthy, K., et al. Influenza vaccine effectiveness in the United States during 2012–2013: variable protection by age and virus type. J Infect Dis 211 (2015), 1529–1540.
9. Gaglani, M., Pruszynski, J., Murthy, K., Clipper, L., Robertson, A., Reis, M., et al. Influenza vaccine effectiveness against 2009 pandemic influenza A(H1N1) virus differed by vaccine type during 2013–2014 in the United States. J Infect Dis 213 (2016), 1546–1556.
10. Treanor, J.J., Talbot, H.K., Ohmit, S.E., Coleman, L.A., Thompson, M.G., Cheng, P.Y., et al. Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains. Clin Infect Dis 55 (2012), 951–959.
11. Zimmerman RK, Nowalk MP, Chung J, Jackson ML, Jackson LA, Petrie JG, et al. 2014-2015 influenza vaccine effectiveness in the United States by vaccine type. Clin Infect Dis 2016;15;63(12):1564–73.
12. Belongia, E.A., Simpson, M.D., King, J.P., Sundaram, M.E., Kelley, N.S., Osterholm, M.T., et al. Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies. Lancet Infect Dis 16 (2016), 942–951.
13. Ferdinands, J.M., Fry, A.M., Reynolds, S., Petrie, J., Flannery, B., Jackson, M.L., et al. Intraseason waning of influenza vaccine protection: evidence from the US influenza vaccine effectiveness network, 2011–12 through 2014–15. Clin Infect Dis 64:5 (2017), 544–550.
14. Osterholm, M.T., Kelley, N.S., Sommer, A., Belongia, E.A., Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 12 (2012), 36–44.
15. Fiore, A.E., Uyeki, T.M., Broder, K., Finelli, L., Euler, G.L., Singleton, J.A., et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 59 (2010), 1–62.
16. Jackson, M.L., Nelson, J.C., The test-negative design for estimating influenza vaccine effectiveness. Vaccine 31 (2013), 2165–2168.
17. Foppa, I.M., Haber, M., Ferdinands, J.M., Shay, D.K., The case test-negative design for studies of the effectiveness of influenza vaccine. Vaccine 31 (2013), 3104–3109.
18. Martinez-Baz, I., Casado, I., Navascues, A., Diaz-Gonzalez, J., Aguinaga, A., Barrado, L., et al. Effect of repeated vaccination with the same vaccine component against 2009 pandemic influenza A(H1N1) virus. J Infect Dis 215 (2017), 847–855.
19. Ohmit, S.E., Petrie, J.G., Malosh, R.E., Cowling, B.J., Thompson, M.G., Shay, D.K., et al. Influenza vaccine effectiveness in the community and the household. Clin Infec Dis 56 (2013), 1363–1369.
20. Skowronski, D.M., Chambers, C., Sabaiduc, S., et al. A perfect storm: impact of genomic variation and serial vaccination on low influenza vaccine effectiveness during the 2014–2015 season. Clin Infect Dis 63 (2016), 21–32.
21. Centers for Disease Control and Prevention. FluVaxView Influenza Vaccination Coverage; 2016 < https://www.cdc.gov/flu/fluvaxview/reportshtml/trends/index.html> [accessed 20 April, 2017].
22. Beyer, W.E., Palache, A.M., Baljet, M., Masurel, N., Antibody induction by influenza vaccines in the elderly: a review of the literature. Vaccine 7 (1989), 385–394.
23. Goodwin, K., Viboud, C., Simonsen, L., Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 24 (2006), 1159–1169.
24. Smith, N.M., Bresee, J.S., Shay, D.K., Uyeki, T.M., Cox, N.J., Strikas, R.A., Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 55 (2006), 1–42.
25. McElhaney, J.E., Zhou, X., Talbot, H.K., Soethout, E., Bleackley, R.C., Granville, D.J., et al. The unmet need in the elderly: how immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines. Vaccine 30 (2012), 2060–2067.
26. Young, B., Zhao, X., Cook, A.R., Parry, C.M., Wilder-Smith, A., MC IC. Do antibody responses to the influenza vaccine persist year-round in the elderly? A systematic review and meta-analysis. Vaccine 35 (2017), 212–221.
27. Belongia, E.A., Sundaram, M.E., McClure, D.L., Meece, J.K., Ferdinands, J., VanWormer, J.J., Waning vaccine protection against influenza A (H3N2) illness in children and older adults during a single season. Vaccine 33 (2015), 246–251.
28. Mosterin Hopping, A., McElhaney, J., Fonville, J.M., Powers, D.C., Beyer, W.E., Smith, D.J., The confounded effects of age and exposure history in response to influenza vaccination. Vaccine 34:4 (2016), 540–546.
29. De Donato, S., Granoff, D., Minutello, M., Lecchi, G., Faccini, M., Agnello, M., et al. Safety and immunogenicity of MF59-adjuvanted influenza vaccine in the elderly. Vaccine 17 (1999), 3094–3101.
30. U.S. Food and Drug Administration. Fluad; 2016 < https://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/VaccineSafety/ucm473989.htm> [accessed 12 May, 2017].
31. DiazGrandados, C., Dunning, A., Kimmel, M., Kirby, D., Treanor, J., Collins, A., et al. Efficacy of high-dose versus standard-dose influenza vaccine in older adults. N Engl J Med 37:7 (2014), 635–645.
32. DiazGranados, C.A., Dunning, A.J., Jordanov, E., Landolfi, V., Denis, M., Talbot, H.K., High-dose trivalent influenza vaccine compared to standard dose vaccine in elderly adults: safety, immunogenicity and relative efficacy during the 2009–2010 season. Vaccine 31 (2013), 861–866.
33. Darvishian, M., Bijlsa, M.J., Hak, E., van den Heuvel, E.R., Effectiveness of seasonal influenza vaccine in community-dwelling elderly people: a meta-analysis of test-negative design case-control studies. Lancet Infect Dis 14 (2014), 1228–1239.
34. Centers for Disease Control and Prevention. Influenza vaccination coverage estimates for persons 6 months and older by State, HHS Region, and the United States, National Immunization Survey-Flu (NIS-Flu) and Behavioral Risk Factor Surveillance System (BRFSS), 2010-11 through 2015-16 influenza seasons; 2016 < http://www.cdc.gov/flu/fluvaxview/reportshtml/trends/index.html> [accessed 5 December, 2016].
35. Ohmit, S.E., Petrie, J.G., Malosh, R.E., Fry, A.M., Thompson, M.G., Monto, A.S., Influenza vaccine effectiveness in households with children during the 2012–2013 season: assessments of prior vaccination and serologic susceptibility. J Infect Dis 211 (2015), 1519–1528.
36. McLean, H.Q., Thompson, M.G., Sundaram, M.E., Meece, J.K., McClure, D.L., Friedrich, T.C., et al. Impact of repeated vaccination on vaccine effectiveness against influenza A(H3N2) and B during 8 seasons. Clin Infect Dis 59 (2014), 1375–1385.
37. Kucharski, A.J., Kwok, K.O., Wei, V.W., Cowling, B.J., Read, J.M., Lessler, J., et al. The contribution of social behaviour to the transmission of influenza A in a human population. PLoS Pathogens, 10, 2014, e1004206.
38. Biggerstaff, M., Jhung, M.A., Reed, C., Fry, A.M., Balluz, L., Finelli, L., Influenza-like illness, the time to seek healthcare, and influenza antiviral receipt during the 2010–2011 influenza season-United States. J Infect Dis 210 (2014), 535–544.
39. Orenstein, E.W., De Serres, G., Haber, M.J., Shay, D.K., Bridges, C.B., Gargiullo, P., et al. Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. Int J Epidemiol 36 (2007), 623–631.
40. Ferdinands, J.M., Shay, D.K., Magnitude of potential biases in a simulated case-control study of the effectiveness of influenza vaccination. Clin Infect Dis 54 (2012), 25–32.